MEA Veterinary Pain Management Market - Industry Trends and Forecast to 2033

TABLE OF CONTENTS

1 INTRODUCTION 60

• 1.1 OBJECTIVES OF THE STUDY 60
• 1.2 MARKET DEFINITION 60
• 1.3 OVERVIEW OF THE MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET 60
• 1.4 CURRENCY AND PRICING 62
• 1.5 LIMITATIONS 62
• 1.6 MARKETS COVERED 63

2 MARKET SEGMENTATION 66

• 2.1 MARKETS COVERED 66
• 2.2 GEOGRAPHICAL SCOPE 67
• 2.3 YEARS CONSIDERED FOR THE STUDY 68
• 2.4 DBMR TRIPOD DATA VALIDATION MODEL 69
• 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 72
• 2.6 MULTIVARIATE MODELLING 73
• 2.7 MARKET END USER COVERAGE GRID 73
• 2.8 PRODUCT LIFELINE CURVE 74
• 2.9 DBMR MARKET POSITION GRID 75
• 2.10 VENDOR SHARE ANALYSIS 76
• 2.11 SECONDARY SOURCES 77
• 2.12 ASSUMPTIONS 77

3 EXECUTIVE SUMMARY 78

4 PREMIUM INSIGHTS 81

• 4.1 PESTEL ANALYSIS 82
• 4.2 PORTER'S FIVE FORCES 83
• 4.3 BRAND REVENUE ANALYSIS 84

5 MARKET OVERVIEW 85

• 5.1 DRIVERS 87
  • 5.1.1 INCREASING PET OWNERSHIP 87
  • 5.1.2 ADVANCEMENTS IN VETERINARY MEDICINE 87
  • 5.1.3 GROWING INCIDENCES OF PET DISEASES 88
  • 5.1.4 INCREASED GOVERNMENT PROJECTS TO ENHANCE ANIMAL CARE 88
• 5.2 RESTRAINTS 89
  • 5.2.1 INCREASING PET CARE COSTS 89
  • 5.2.2 STRICT REGULATORY GUIDELINES 89 
• 5.3 OPPORTUNITIES 90
  • 5.3.1 RISING R&D ACTIVITIES AND PRODUCT APPROVAL FOR VETERINARY PAIN MANAGEMENT 90
  • 5.3.2 RISING POPULARITY OF NON- CONVENTIONAL TREATMENT APPROACHES 91
  • 5.3.3 TECHNOLOGICAL ADVANCEMENTS 91
• 5.4 CHALLENGES 92
  • 5.4.1 LIMITED AVAILABILITY OF VETERINARIANS 92
  • 5.4.2 RESISTANCE TO MEDICATIONS 92

6 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE 93

• 6.1 OVERVIEW 94
• 6.2 ANALGESICS 95
  • 6.2.1 ANTI- INFLAMMATORY (NSAIDS) 96
    • 6.2.1.1 CARPROFEN 96
    • 6.2.1.2 MELOXICAM 96
    • 6.2.1.3 PHENYLBUTAZONE 96
    • 6.2.1.4 ACETAMINOPHEN 96
    • 6.2.1.5 FIROCOXIB 96
    • 6.2.1.6 DERACOXIB 97
    • 6.2.1.7 OTHERS 97
  • 6.2.2 OPIOIDS 97
    • 6.2.2.1 MU AGONISTS 97
      • 6.2.2.1.1 METHADONE 99
      • 6.2.2.1.2 MEPERIDINE 99
      • 6.2.2.1.3 MORPHINE 99
      • 6.2.2.1.4 OXYMORPHONE 99
      • 6.2.2.1.5 OTHERS 99
    • 6.2.2.2 PARTIAL MU AGONIST 99
      • 6.2.2.2.1 BUPRENORPHINE 99
      • 6.2.2.2.2 OTHERS 100
    • 6.2.2.3 KAPPA AGONIST MU ANTAGONIST 100
      • 6.2.2.3.1 BUTORPHANOL 100
      • 6.2.2.3.2 OTHERS 100
• 6.3 CORTICOSTEROIDS 101
  • 6.3.1 DEXAMETHASONE 101
  • 6.3.2 PREDNISOLONE 101
  • 6.3.3 PREDNISONE 101
  • 6.3.4 OTHERS 102
• 6.4 ALPHA 2 AGONISTS 102

7 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE 103

• 7.1 OVERVIEW 104
• 7.2 BRANDED 105
• 7.3 GENERIC 105

8 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE 107

• 8.1 OVERVIEW 108
• 8.2 PRESCRIPTION BASED 109
• 8.3 OTC 109

9 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE 111

• 9.1 OVERVIEW 112
• 9.2 COMPANION ANIMAL 113
  • 9.2.1 CANINE 114
  • 9.2.2 EQUINE 114
  • 9.2.3 FELINE 114
  • 9.2.4 OTHERS 114
• 9.3 PRODUCTION ANIMAL 114
  • 9.3.1 CATTLE 115
  • 9.3.2 SWINE 115
  • 9.3.3 POULTRY 115
  • 9.3.4 FISH 115
  • 9.3.5 OTHERS 115

10 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE 116

• 10.1 OVERVIEW 117
• 10.2 CHRONIC PAIN 118
• 10.3 ACUTE PAIN 119
• 10.4 POST OPERATIVE PAIN 119
• 10.5 DENTAL PAIN 120 

11 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE 121

• 11.1 OVERVIEW 122
• 11.2 SOLID 123
  • 11.2.1 TABLET 124
  • 11.2.2 POWDER 124
  • 11.2.3 OTHERS 124
• 11.3 LIQUID 124
  • 11.3.1 SOLUTION 125
  • 11.3.2 SYRUP 125
  • 11.3.3 SUSPENSION 125
  • 11.3.4 OTHERS 125
• 11.4 SEMI SOLID 125
  • 11.4.1 GEL 126
  • 11.4.2 CREAM 126
  • 11.4.3 OTHERS 126

12 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION 127

• 12.1 OVERVIEW 128
• 12.2 PARENTERAL 129
• 12.3 ORAL 130
• 12.4 TOPICAL 130

13 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY END USER 131

• 13.1 OVERVIEW 132
• 13.2 VETERINARY HOSPITALS 133
• 13.3 VETERINARY CLINICS 134
• 13.4 PET SHOPS 134
• 13.5 ANIMAL FARMS 135
• 13.6 ACADEMIC & RESEARCH INSTITUTES 135
• 13.7 OTHERS 136 

14 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY GEOGRAPHY 137

• 14.1 MIDDLE EAST AND AFRICA 138
  • 14.1.1 SOUTH AFRICA 146
  • 14.1.2 SAUDI ARABIA 153
  • 14.1.3 U.A.E. 160
  • 14.1.4 EGYPT 167
  • 14.1.5 ISRAEL 174
  • 14.1.6 KUWAIT 181
  • 14.1.7 OMAN 188
  • 14.1.8 QATAR 195
  • 14.1.9 BAHRAIN 202
  • 14.1.10 REST OF MIDDLE EAST AND AFRICA 209

15 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, COMPANY LANDSCAPE 210

• 15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA 210

16 SWOT ANALYSIS 211

17 COMPANY PROFILE 212

• 17.1 ZOETIS SERVICES LLC 212
  • 17.1.1 COMPANY SNAPSHOT 212
  • 17.1.2 COMPANY SHARE ANALYSIS 212
  • 17.1.3 PRODUCT PORTFOLIO 213
  • 17.1.4 RECENT DEVELOPMENTS 213
• 17.2 ELANCO 214
  • 17.2.1 COMPANY SNAPSHOT 214
  • 17.2.2 REVENUE ANALYSIS 214
  • 17.2.3 COMPANY SHARE ANALYSIS 215
  • 17.2.4 PRODUCT PORTFOLIO 215
  • 17.2.5 RECENT DEVELOPMENT 215
• 17.3 MERCK & CO., INC. 216
  • 17.3.1 COMPANY SNAPSHOT 216
  • 17.3.2 REVENUE ANALYSIS 216
  • 17.3.3 COMPANY SHARE ANALYSIS 217
  • 17.3.4 PRODUCT PORTFOLIO 217
  • 17.3.5 RECENT DEVELOPMENT 217 
• 17.4 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 218
  • 17.4.1 COMPANY SNAPSHOT 218
  • 17.4.2 COMPANY SHARE ANALYSIS 218
  • 17.4.3 PRODUCT PORTFOLIO 219
  • 17.4.4 RECENT DEVELOPMENT 219
• 17.5 VETOQUINOL 220
  • 17.5.1 COMPANY SNAPSHOT 220
  • 17.5.2 REVENUE ANALYSIS 220
  • 17.5.3 COMPANY SHARE ANALYSIS 221
  • 17.5.4 PRODUCT PORTFOLIO 221
  • 17.5.5 RECENT DEVELOPMENTS 221
• 17.6 BIMEDA, INC. 223
  • 17.6.1 COMPANY SNAPSHOT 223
  • 17.6.2 PRODUCT PORTFOLIO 223
  • 17.6.3 RECENT DEVELOPMENT 223
• 17.7 CEVA ANIMAL HEALTH, LLC 224
  • 17.7.1 COMPANY SNAPSHOT 224
  • 17.7.2 PRODUCT PORTFOLIO 224
  • 17.7.3 RECENT DEVELOPMENT 224
• 17.8 CHANELLE PHARMA 225
  • 17.8.1 COMPANY SNAPSHOT 225
  • 17.8.2 PRODUCT PORTFOLIO 225
  • 17.8.3 RECENT DEVELOPMENT 225
• 17.9 DECHRA PHARMACEUTICALS PLC 226
  • 17.9.1 COMPANY SNAPSHOT 226
  • 17.9.2 REVENUE ANALYSIS 226
  • 17.9.3 PRODUCT PORTFOLIO 227
  • 17.9.4 RECENT DEVELOPMENTS 227
• 17.10 DURVET ANIMAL HEALTH PRODUCTS 228
  • 17.10.1 COMPANY SNAPSHOT 228
  • 17.10.2 PRODUCT PORTFOLIO 228
  • 17.10.3 RECENT DEVELOPMENT 228
• 17.11 INOVET (A SUBSIDIARY OF ORION GROUP) 229
  • 17.11.1 COMPANY SNAPSHOT 229
  • 17.11.2 PRODUCT PORTFOLIO 229
  • 17.11.3 RECENT DEVELOPMENTS 229 
• 17.12 NORBROOK 231
  • 17.12.1 COMPANY SNAPSHOT 231
  • 17.12.2 PRODUCT PORTFOLIO 231
  • 17.12.3 RECENT DEVELOPMENT 231
• 17.13 VIRBAC 232
  • 17.13.1 COMPANY SNAPSHOT 232
  • 17.13.2 REVENUE ANALYSIS 232
  • 17.13.3 PRODUCT PORTFOLIO 233
  • 17.13.4 RECENT DEVELOPMENT 233

18 QUESTIONNAIRE 234

19 RELATED REPORTS 238

LIST OF TABLES

• TABLE 1 BRAND REVENUE ANALYSIS FOR VETERINARY PAIN MANAGEMENT MARKET 47
• TABLE 2 NUMBER OF U.S. HOUSEHOLD-OWNED PET ANIMALS 50
• TABLE 3 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 58
• TABLE 4 MIDDLE EAST AND AFRICA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 58
• TABLE 5 MIDDLE EAST AND AFRICA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 58
• TABLE 6 MIDDLE EAST AND AFRICA ANTI- INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 59
• TABLE 7 MIDDLE EAST AND AFRICA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 60
• TABLE 8 MIDDLE EAST AND AFRICA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 60
• TABLE 9 MIDDLE EAST AND AFRICA PARTIAL MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 62
• TABLE 10 MIDDLE EAST AND AFRICA KAPPA AGONIST MU ANTAGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 63
• TABLE 11 MIDDLE EAST AND AFRICA CORTICOSTEROIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 64
• TABLE 12 MIDDLE EAST AND AFRICA CORTICOSTEROIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 64
• TABLE 13 MIDDLE EAST AND AFRICA ALPHA-2 AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 65
• TABLE 14 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 68
• TABLE 15 MIDDLE EAST AND AFRICA BRANDED IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 68
• TABLE 16 MIDDLE EAST AND AFRICA GENERIC IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 68
• TABLE 17 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 72
• TABLE 18 MIDDLE EAST AND AFRICA PRESCRIPTION BASED IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 72
• TABLE 19 MIDDLE EAST AND AFRICA OTC IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 72
• TABLE 20 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 76
• TABLE 21 MIDDLE EAST AND AFRICA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 76
• TABLE 22 MIDDLE EAST AND AFRICA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 76
• TABLE 23 MIDDLE EAST AND AFRICA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 77
• TABLE 24 MIDDLE EAST AND AFRICA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 78
• TABLE 25 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 81
• TABLE 26 MIDDLE EAST AND AFRICA CHRONIC PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 81
• TABLE 27 MIDDLE EAST AND AFRICA ACUTE PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 82
• TABLE 28 MIDDLE EAST AND AFRICA POST OPERATIVE PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 82
• TABLE 29 MIDDLE EAST AND AFRICA DENTAL PAIN IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 83
• TABLE 30 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 86
• TABLE 31 MIDDLE EAST AND AFRICA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 86
• TABLE 32 MIDDLE EAST AND AFRICA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 86
• TABLE 33 MIDDLE EAST AND AFRICA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 87
• TABLE 34 MIDDLE EAST AND AFRICA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 87
• TABLE 35 MIDDLE EAST AND AFRICA SEMI SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 88
• TABLE 36 MIDDLE EAST AND AFRICA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 88
• TABLE 37 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 92
• TABLE 38 MIDDLE EAST AND AFRICA PARENTERAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 92
• TABLE 39 MIDDLE EAST AND AFRICA ORAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 93
• TABLE 40 MIDDLE EAST AND AFRICA TOPICAL IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 93
• TABLE 41 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 96
• TABLE 42 MIDDLE EAST AND AFRICA VETERINARY HOSPITALS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 96
• TABLE 43 MIDDLE EAST AND AFRICA VETERINARY CLINICS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 97
• TABLE 44 MIDDLE EAST AND AFRICA PET SHOPS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 97
• TABLE 45 MIDDLE EAST AND AFRICA ANIMAL FARMS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 98
• TABLE 46 MIDDLE EAST AND AFRICA ACADEMIC & RESEARCH INSTITUTES IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 98
• TABLE 47 MIDDLE EAST AND AFRICA OTHERS IN VETERINARY PAIN MANAGEMENT MARKET, BY REGION, 2021-2030 (USD THOUSAND) 99
• TABLE 48 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 101
• TABLE 49 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 101
• TABLE 50 MIDDLE EAST AND AFRICA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 102
• TABLE 51 MIDDLE EAST AND AFRICA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 102
• TABLE 52 MIDDLE EAST AND AFRICA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 102
• TABLE 53 MIDDLE EAST AND AFRICA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 103
• TABLE 54 MIDDLE EAST AND AFRICA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 103
• TABLE 55 MIDDLE EAST AND AFRICA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 103
• TABLE 56 MIDDLE EAST AND AFRICA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 104
• TABLE 57 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 104
• TABLE 58 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 104
• TABLE 59 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 105
• TABLE 60 MIDDLE EAST AND AFRICA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 105
• TABLE 61 MIDDLE EAST AND AFRICA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 105
• TABLE 62 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 106
• TABLE 63 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 106
• TABLE 64 MIDDLE EAST AND AFRICA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 106
• TABLE 65 MIDDLE EAST AND AFRICA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 107
• TABLE 66 MIDDLE EAST AND AFRICA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 107
• TABLE 67 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 107
• TABLE 68 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 108
• TABLE 69 SOUTH AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 109
• TABLE 70 SOUTH AFRICA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 109
• TABLE 71 SOUTH AFRICA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 109
• TABLE 72 SOUTH AFRICA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 110
• TABLE 73 SOUTH AFRICA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 110
• TABLE 74 SOUTH AFRICA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 110
• TABLE 75 SOUTH AFRICA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 111
• TABLE 76 SOUTH AFRICA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 111
• TABLE 77 SOUTH AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 111
• TABLE 78 SOUTH AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 112
• TABLE 79 SOUTH AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 112
• TABLE 80 SOUTH AFRICA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 112
• TABLE 81 SOUTH AFRICA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 113
• TABLE 82 SOUTH AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 113
• TABLE 83 SOUTH AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 113
• TABLE 84 SOUTH AFRICA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 114
• TABLE 85 SOUTH AFRICA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 114
• TABLE 86 SOUTH AFRICA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 114
• TABLE 87 SOUTH AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 115
• TABLE 88 SOUTH AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 115
• TABLE 89 SAUDI ARABIA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
• TABLE 90 SAUDI ARABIA ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
• TABLE 91 SAUDI ARABIA ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 116
• TABLE 92 SAUDI ARABIA OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 117
• TABLE 93 SAUDI ARABIA MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 117
• TABLE 94 SAUDI ARABIA PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 117
• TABLE 95 SAUDI ARABIA KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 118
• TABLE 96 SAUDI ARABIA CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 118
• TABLE 97 SAUDI ARABIA VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 118
• TABLE 98 SAUDI ARABIA VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 119
• TABLE 99 SAUDI ARABIA VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 119
• TABLE 100 SAUDI ARABIA COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 119
• TABLE 101 SAUDI ARABIA PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 120
• TABLE 102 SAUDI ARABIA VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 120
• TABLE 103 SAUDI ARABIA VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 120
• TABLE 104 SAUDI ARABIA SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 121
• TABLE 105 SAUDI ARABIA LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 121
• TABLE 106 SAUDI ARABIA SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 121
• TABLE 107 SAUDI ARABIA VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 122
• TABLE 108 SAUDI ARABIA VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 122
• TABLE 109 U.A.E. VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 123
• TABLE 110 U.A.E. ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 123
• TABLE 111 U.A.E. ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 123
• TABLE 112 U.A.E. OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
• TABLE 113 U.A.E. MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
• TABLE 114 U.A.E. PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 124
• TABLE 115 U.A.E. KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
• TABLE 116 U.A.E. CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 125
• TABLE 117 U.A.E. VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 125
• TABLE 118 U.A.E. VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 126
• TABLE 119 U.A.E. VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 126
• TABLE 120 U.A.E. COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 126
• TABLE 121 U.A.E. PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 127
• TABLE 122 U.A.E. VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 127
• TABLE 123 U.A.E. VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 127
• TABLE 124 U.A.E. SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 128
• TABLE 125 U.A.E. LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 128
• TABLE 126 U.A.E. SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 128
• TABLE 127 U.A.E. VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 129
• TABLE 128 U.A.E. VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 129
• TABLE 129 EGYPT VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
• TABLE 130 EGYPT ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
• TABLE 131 EGYPT ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 130
• TABLE 132 EGYPT OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
• TABLE 133 EGYPT MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
• TABLE 134 EGYPT PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 131
• TABLE 135 EGYPT KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
• TABLE 136 EGYPT CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 132
• TABLE 137 EGYPT VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 132
• TABLE 138 EGYPT VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 133
• TABLE 139 EGYPT VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 133
• TABLE 140 EGYPT COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 133
• TABLE 141 EGYPT PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 134
• TABLE 142 EGYPT VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 134
• TABLE 143 EGYPT VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 134
• TABLE 144 EGYPT SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 135
• TABLE 145 EGYPT LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 135
• TABLE 146 EGYPT SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 135
• TABLE 147 EGYPT VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 136
• TABLE 148 EGYPT VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 136
• TABLE 149 ISRAEL VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 137
• TABLE 150 ISRAEL ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 137
• TABLE 151 ISRAEL ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 137
• TABLE 152 ISRAEL OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
• TABLE 153 ISRAEL MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
• TABLE 154 ISRAEL PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 138
• TABLE 155 ISRAEL KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 139
• TABLE 156 ISRAEL CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 139
• TABLE 157 ISRAEL VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 139
• TABLE 158 ISRAEL VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 140
• TABLE 159 ISRAEL VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 140

• TABLE 160 ISRAEL COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 140
• TABLE 161 ISRAEL PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 141
• TABLE 162 ISRAEL VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 141
• TABLE 163 ISRAEL VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 141
• TABLE 164 ISRAEL SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 142
• TABLE 165 ISRAEL LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 142
• TABLE 166 ISRAEL SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 142
• TABLE 167 ISRAEL VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 143
• TABLE 168 ISRAEL VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 143
• TABLE 169 KUWAIT VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 144
• TABLE 170 KUWAIT ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 144
• TABLE 171 KUWAIT ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 144
• TABLE 172 KUWAIT OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
• TABLE 173 KUWAIT MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
• TABLE 174 KUWAIT PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 145
• TABLE 175 KUWAIT KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
• TABLE 176 KUWAIT CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 146
• TABLE 177 KUWAIT VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 146
• TABLE 178 KUWAIT VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 147
• TABLE 179 KUWAIT VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 147
• TABLE 180 KUWAIT COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 147
• TABLE 181 KUWAIT PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 148
• TABLE 182 KUWAIT VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 148
• TABLE 183 KUWAIT VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 148
• TABLE 184 KUWAIT SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 149
• TABLE 185 KUWAIT LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 149
• TABLE 186 KUWAIT SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 149
• TABLE 187 KUWAIT VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 150
• TABLE 188 KUWAIT VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 150
• TABLE 189 OMAN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
• TABLE 190 OMAN ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
• TABLE 191 OMAN ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 151
• TABLE 192 OMAN OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 152
• TABLE 193 OMAN MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 152
• TABLE 194 OMAN PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 152
• TABLE 195 OMAN KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 153
• TABLE 196 OMAN CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 153
• TABLE 197 OMAN VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 153
• TABLE 198 OMAN VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 154
• TABLE 199 OMAN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 154
• TABLE 200 OMAN COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 154
• TABLE 201 OMAN PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 155
• TABLE 202 OMAN VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 155
• TABLE 203 OMAN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 155
• TABLE 204 OMAN SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 156
• TABLE 205 OMAN LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 156
• TABLE 206 OMAN SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 156
• TABLE 207 OMAN VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 157
• TABLE 208 OMAN VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 157
• TABLE 209 QATAR VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
• TABLE 210 QATAR ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
• TABLE 211 QATAR ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 158
• TABLE 212 QATAR OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
• TABLE 213 QATAR MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
• TABLE 214 QATAR PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 159
• TABLE 215 QATAR KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 160
• TABLE 216 QATAR CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 160
• TABLE 217 QATAR VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 160
• TABLE 218 QATAR VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 161
• TABLE 219 QATAR VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 161
• TABLE 220 QATAR COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 161
• TABLE 221 QATAR PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 162
• TABLE 222 QATAR VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 162
• TABLE 223 QATAR VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 162
• TABLE 224 QATAR SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 163
• TABLE 225 QATAR LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 163
• TABLE 226 QATAR SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 163
• TABLE 227 QATAR VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 164
• TABLE 228 QATAR VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 164
• TABLE 229 BAHRAIN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
• TABLE 230 BAHRAIN ANALGESICS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
• TABLE 231 BAHRAIN ANTI-INFLAMMATORY (NSAIDS) IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 165
• TABLE 232 BAHRAIN OPIOIDS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
• TABLE 233 BAHRAIN MU AGONISTS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
• TABLE 234 BAHRAIN PARTIAL MU AGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 166
• TABLE 235 BAHRAIN KAPPA AGONIST-MU ANTAGONIST IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
• TABLE 236 BAHRAIN CORTECOSTERIODS IN VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 167
• TABLE 237 BAHRAIN VETERINARY PAIN MANAGEMENT MARKET, BY DRUG TYPE, 2021-2030 (USD THOUSAND) 167
• TABLE 238 BAHRAIN VETERINARY PAIN MANAGEMENT MARKET, BY MODE OF PURCHASE, 2021-2030 (USD THOUSAND) 168
• TABLE 239 BAHRAIN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 168
• TABLE 240 BAHRAIN COMPANION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 168
• TABLE 241 BAHRAIN PRODUCTION ANIMAL IN VETERINARY PAIN MANAGEMENT MARKET, BY ANIMAL TYPE, 2021-2030 (USD THOUSAND) 169
• TABLE 242 BAHRAIN VETERINARY PAIN MANAGEMENT MARKET, BY PAIN SOURCE, 2021-2030 (USD THOUSAND) 169
• TABLE 243 BAHRAIN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 169
• TABLE 244 BAHRAIN SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 170
• TABLE 245 BAHRAIN LIQUID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 170
• TABLE 246 BAHRAIN SEMI-SOLID IN VETERINARY PAIN MANAGEMENT MARKET, BY DOSAGE, 2021-2030 (USD THOUSAND) 170
• TABLE 247 BAHRAIN VETERINARY PAIN MANAGEMENT MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD THOUSAND) 171
• TABLE 248 BAHRAIN VETERINARY PAIN MANAGEMENT MARKET, BY END USER, 2021-2030 (USD THOUSAND) 171
• TABLE 249 REST OF MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND) 172

LIST OF FIGURES

• FIGURE 1 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: SEGMENTATION 28
• FIGURE 2 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: DATA TRIANGULATION 31
• FIGURE 3 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: DROC ANALYSIS 32
• FIGURE 4 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS 33
• FIGURE 5 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: COMPANY RESEARCH ANALYSIS 33
• FIGURE 6 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: INTERVIEW DEMOGRAPHICS 34
• FIGURE 7 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: MARKET END USER COVERAGE GRID 35
• FIGURE 8 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: DBMR MARKET POSITION GRID 37
• FIGURE 9 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: VENDOR SHARE ANALYSIS 38
• FIGURE 10 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: SEGMENTATION 42
• FIGURE 11 INCREASING PET OWNERSHIP AND ADVANCEMENTS IN VETERINARY MEDICINE ARE EXPECTED TO DRIVE THE GROWTH OF THE MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET FROM 2023 TO 2030 43
• FIGURE 12 THE ANALGESICS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET IN 2023 & 2030 43
• FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES FOR MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET 48
• FIGURE 14 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: BY PRODUCT TYPE, 2022 56
• FIGURE 15 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: BY DRUG TYPE, 2022 66
• FIGURE 16 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: BY MODE OF PURCHASE, 2022 70
• FIGURE 17 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: BY ANIMAL TYPE, 2022 74
• FIGURE 18 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: BY PAIN SOURCE, 2022 79
• FIGURE 19 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: BY DOSAGE, 2022 84
• FIGURE 20 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: BY ROUTE OF ADMINISTRATION, 2022 90
• FIGURE 21 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: BY END USER, 2022 94
• FIGURE 22 MIDDLE EAST AND AFRICA VETERINARY PAIN MANAGEMENT MARKET: COMPANY SHARE 2022 (%) 172